These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 12975750)

  • 1. Advances against aspergillosis.
    Steinbach WJ; Stevens DA; Denning DW; Moss RB
    Clin Infect Dis; 2003 Oct; 37 Suppl 3():S155-6. PubMed ID: 12975750
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination therapy with terbinafine and amphotericin B in a rabbit model of experimental invasive aspergillosis.
    Kirkpatrick WR; Vallor AC; McAtee RK; Ryder NS; Fothergill AW; Rinaldi MG; Patterson TF
    Antimicrob Agents Chemother; 2005 Nov; 49(11):4751-3. PubMed ID: 16251321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple-triazole-resistant aspergillosis.
    Verweij PE; Mellado E; Melchers WJ
    N Engl J Med; 2007 Apr; 356(14):1481-3. PubMed ID: 17409336
    [No Abstract]   [Full Text] [Related]  

  • 4. Intracranial aspergillosis in children successfully treated with antifungal therapy and surgical intervention.
    Giacchino M; Chiapello N; Riva C; Scolfaro C; Pultrone M; Valera M; Peretta P; Piglione M; Di Rosa G; Tovo PA
    Pediatr Infect Dis J; 2006 Apr; 25(4):379-81. PubMed ID: 16567999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment failure in invasive aspergillosis: susceptibility of deep tissue isolates following treatment with amphotericin B.
    Paterson PJ; Seaton S; Prentice HG; Kibbler CC
    J Antimicrob Chemother; 2003 Nov; 52(5):873-6. PubMed ID: 14519673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma.
    Chen J; Li H; Li R; Bu D; Wan Z
    J Antimicrob Chemother; 2005 Jan; 55(1):31-7. PubMed ID: 15563516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo resistance of a laboratory-selected Aspergillus fumigatus isolate to amphotericin B.
    Manavathu EK; Cutright JL; Chandrasekar PH
    Antimicrob Agents Chemother; 2005 Jan; 49(1):428-30. PubMed ID: 15616327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on antifungal drug resistance mechanisms of Aspergillus fumigatus.
    Chamilos G; Kontoyiannis DP
    Drug Resist Updat; 2005 Dec; 8(6):344-58. PubMed ID: 16488654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of newer antifungal and immunomodulatory strategies for invasive aspergillosis.
    Steinbach WJ; Stevens DA
    Clin Infect Dis; 2003 Oct; 37 Suppl 3():S157-87. PubMed ID: 12975751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of ambruticin analogs in a murine model of invasive pulmonary aspergillosis.
    Chiang LY; Ejzykowicz DE; Tian ZQ; Katz L; Filler SG
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3464-6. PubMed ID: 17005833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infectious diseases. Farm fungicides linked to resistance in a human pathogen.
    Enserink M
    Science; 2009 Nov; 326(5957):1173. PubMed ID: 19965440
    [No Abstract]   [Full Text] [Related]  

  • 12. Voriconazole concentrations in synovial fluid and bone tissues.
    Denes E; Boumediene A; Durox H; Oksman A; Saint-Marcoux F; Darde ML; Gaulier JM
    J Antimicrob Chemother; 2007 Apr; 59(4):818-9. PubMed ID: 17329266
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful treatment of aspergillus brain abscess with itraconazole and interferon-gamma in a patient with chronic granulomatous disease.
    Saulsbury FT
    Clin Infect Dis; 2001 May; 32(10):E137-9. PubMed ID: 11317265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspergillus fumigatus endocarditis of the mitral valve in a heart transplant recipient: a case report.
    Morio F; Treilhaud M; Lepelletier D; Le Pape P; Rigal JC; Delile L; Robert JP; Al Habash O; Miegeville M; Gay-Andrieu F
    Diagn Microbiol Infect Dis; 2008 Dec; 62(4):453-6. PubMed ID: 18993010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activities at pH 5.0 and pH 7.0 and in vivo efficacy of flucytosine against Aspergillus fumigatus.
    Verweij PE; Te Dorsthorst DT; Janssen WH; Meis JF; Mouton JW
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4483-5. PubMed ID: 18794382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuftsin-mediated immunoprophylaxis against an isolate of Aspergillus fumigatus shows less in vivo susceptibility to amphotericin B.
    Khan MA; Ahmad N; Moin S; Mannan A; Wajahul H; Pasha ST; Khan A; Owais M
    FEMS Immunol Med Microbiol; 2005 Jun; 44(3):269-76. PubMed ID: 15907448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis.
    Chandrasekar PH; Cutright JL; Manavathu EK
    Clin Microbiol Infect; 2004 Oct; 10(10):925-8. PubMed ID: 15373889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poor efficacy of amphotericin B-based therapy in CNS aspergillosis.
    Schwartz S; Ruhnke M; Ribaud P; Reed E; Troke P; Thiel E
    Mycoses; 2007 May; 50(3):196-200. PubMed ID: 17472616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed pulmonary fungal infection with Aspergillus fumigatus and Absidia corymbifera in a patient with relapsed acute myeloid leukaemia.
    McLintock LA; Gibson BE; Jones BL
    Br J Haematol; 2005 Mar; 128(6):737. PubMed ID: 15755275
    [No Abstract]   [Full Text] [Related]  

  • 20. Targeted gene disruption of the 14-alpha sterol demethylase (cyp51A) in Aspergillus fumigatus and its role in azole drug susceptibility.
    Mellado E; Garcia-Effron G; Buitrago MJ; Alcazar-Fuoli L; Cuenca-Estrella M; Rodriguez-Tudela JL
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2536-8. PubMed ID: 15917566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.